S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
S&P 500   3,821.35 (-0.54%)
DOW   31,802.44 (+0.97%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
Log in
NASDAQ:PAVM

PAVmed News Headlines

$3.52
-0.21 (-5.63 %)
(As of 03/8/2021 05:12 PM ET)
Add
Compare
Today's Range
$3.46
Now: $3.52
$3.80
50-Day Range
$2.01
MA: $3.07
$5.55
52-Week Range
$1.30
Now: $3.52
$5.63
Volume2.43 million shs
Average Volume4.85 million shs
Market Capitalization$253.10 million
P/E RatioN/A
Dividend YieldN/A
Beta0.13

Headlines

PAVmed (NASDAQ PAVM) News Headlines Today

Source:
SourceHeadline
PAVmed (NASDAQ:PAVM) Trading Down 10.4%PAVmed (NASDAQ:PAVM) Trading Down 10.4%
americanbankingnews.com - March 4 at 9:08 PM
Form 8-K PAVmed Inc. For: Mar 02 - StreetInsider.comForm 8-K PAVmed Inc. For: Mar 02 - StreetInsider.com
streetinsider.com - March 3 at 5:35 PM
PAVmed Retires Convertible Debt - Yahoo FinancePAVmed Retires Convertible Debt - Yahoo Finance
finance.yahoo.com - March 3 at 5:35 PM
PAVmed Retires Convertible DebtPAVmed Retires Convertible Debt
finance.yahoo.com - March 3 at 12:35 PM
PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors - Yahoo FinancePAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors - Yahoo Finance
finance.yahoo.com - March 2 at 10:50 PM
PAVmed (NASDAQ:PAVM) Trading 5.6% Higher PAVmed (NASDAQ:PAVM) Trading 5.6% Higher
americanbankingnews.com - March 2 at 7:02 PM
Traders Purchase High Volume of Call Options on PAVmed (NASDAQ:PAVM)Traders Purchase High Volume of Call Options on PAVmed (NASDAQ:PAVM)
americanbankingnews.com - March 2 at 2:18 PM
PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors - GlobeNewswirePAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors - GlobeNewswire
globenewswire.com - March 1 at 5:51 PM
PAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of DirectorsPAVmed Chairman and Chief Executive Officer Lishan Aklog, M.D., Elected to AdvaMed Board of Directors
finance.yahoo.com - March 1 at 12:50 PM
PAVmed (NASDAQ:PAVM) Stock Price Down 6%PAVmed (NASDAQ:PAVM) Stock Price Down 6%
americanbankingnews.com - February 26 at 8:01 PM
PAVmed Announces Closing of its Public Offering of Common Stock - Yahoo FinancePAVmed Announces Closing of its Public Offering of Common Stock - Yahoo Finance
finance.yahoo.com - February 26 at 6:37 PM
PAVmed closes - Seeking AlphaPAVmed closes - Seeking Alpha
seekingalpha.com - February 25 at 5:34 PM
PAVmed Announces Closing of its Public Offering of Common StockPAVmed Announces Closing of its Public Offering of Common Stock
finance.yahoo.com - February 25 at 5:34 PM
PAVmed (PAVM) Prices 9.8M Share Common Offering for Gross Proceeds of Approx. $45M - StreetInsider.comPAVmed (PAVM) Prices 9.8M Share Common Offering for Gross Proceeds of Approx. $45M - StreetInsider.com
streetinsider.com - February 23 at 11:44 PM
PAVmed stock slumps on pricing $45M stock offering - Seeking AlphaPAVmed stock slumps on pricing $45M stock offering - Seeking Alpha
seekingalpha.com - February 23 at 11:44 PM
PAVmed Announces Proposed Public Offering of Common Stock - Yahoo FinancePAVmed Announces Proposed Public Offering of Common Stock - Yahoo Finance
finance.yahoo.com - February 23 at 11:44 PM
PAVmed announces proposed public offering - Seeking AlphaPAVmed announces proposed public offering - Seeking Alpha
seekingalpha.com - February 23 at 6:44 PM
PAVmed Announces Pricing of $45 Million Public Offering of Common Stock - Yahoo FinancePAVmed Announces Pricing of $45 Million Public Offering of Common Stock - Yahoo Finance
finance.yahoo.com - February 23 at 6:44 PM
PAVmed (NASDAQ:PAVM) Shares Gap Down to $5.55PAVmed (NASDAQ:PAVM) Shares Gap Down to $5.55
americanbankingnews.com - February 23 at 2:40 PM
Why Is It Moving? Looking Into Why PAVmeds Stock is Trading Lower Today - BenzingaWhy Is It Moving? Looking Into Why PAVmed's Stock is Trading Lower Today - Benzinga
benzinga.com - February 23 at 1:43 PM
PAVmed Announces Pricing of $45 Million Public Offering of Common Stock - GlobeNewswirePAVmed Announces Pricing of $45 Million Public Offering of Common Stock - GlobeNewswire
globenewswire.com - February 23 at 1:43 PM
PAVmed Announces Pricing of $45 Million Public Offering of Common StockPAVmed Announces Pricing of $45 Million Public Offering of Common Stock
finance.yahoo.com - February 23 at 1:43 PM
PAVmed Tanks 12% After-Hours On Lucid Diagnostics Spin-Off - Yahoo FinancePAVmed Tanks 12% After-Hours On Lucid Diagnostics Spin-Off - Yahoo Finance
finance.yahoo.com - February 23 at 8:43 AM
PAVmed (NASDAQ:PAVM) Issues Quarterly  Earnings Results, Misses Estimates By $0.06 EPSPAVmed (NASDAQ:PAVM) Issues Quarterly Earnings Results, Misses Estimates By $0.06 EPS
americanbankingnews.com - February 23 at 8:18 AM
PAVmed (NASDAQ:PAVM) Trading Up 21.4% on Analyst UpgradePAVmed (NASDAQ:PAVM) Trading Up 21.4% on Analyst Upgrade
americanbankingnews.com - February 22 at 6:19 PM
PAVmed (NASDAQ:PAVM) Price Target Raised to $9.00PAVmed (NASDAQ:PAVM) Price Target Raised to $9.00
americanbankingnews.com - February 22 at 5:24 PM
Form 8-K PAVmed Inc. For: Feb 22 - StreetInsider.comForm 8-K PAVmed Inc. For: Feb 22 - StreetInsider.com
streetinsider.com - February 22 at 5:12 PM
PAVmed (PAVM) majority-owned subsidiary Lucid Diagnostics to spin-off into separate public company - StreetInsider.comPAVmed (PAVM) majority-owned subsidiary Lucid Diagnostics to spin-off into separate public company - StreetInsider.com
streetinsider.com - February 22 at 5:12 PM
PAVmeds (PAVM) CEO Lishan Aklog on Business Update and Preliminary Q4 2020 Results - Earnings Call Transcript - Seeking AlphaPAVmed's (PAVM) CEO Lishan Aklog on Business Update and Preliminary Q4 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - February 22 at 5:12 PM
PAVmed - Seeking AlphaPAVmed - Seeking Alpha
seekingalpha.com - February 22 at 5:12 PM
PAVmed Announces Proposed Public Offering of Common Stock - GlobeNewswirePAVmed Announces Proposed Public Offering of Common Stock - GlobeNewswire
globenewswire.com - February 22 at 5:12 PM
PAVmed Announces Proposed Public Offering of Common StockPAVmed Announces Proposed Public Offering of Common Stock
finance.yahoo.com - February 22 at 5:12 PM
PAVmed EPS misses by $0.02 - Seeking AlphaPAVmed EPS misses by $0.02 - Seeking Alpha
seekingalpha.com - February 22 at 12:12 PM
PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results - Yahoo FinancePAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results - Yahoo Finance
finance.yahoo.com - February 22 at 12:12 PM
PAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial ResultsPAVmed Provides Business Update and Preliminary Fourth Quarter 2020 Financial Results
finance.yahoo.com - February 22 at 12:12 PM
PAVmed (NASDAQ:PAVM) Releases Q4 2020
Pre-Market Earnings GuidancePAVmed (NASDAQ:PAVM) Releases Q4 2020 Pre-Market Earnings Guidance
americanbankingnews.com - February 22 at 9:12 AM
PAVmed (NASDAQ:PAVM) Issues FY 2020
Pre-Market Earnings GuidancePAVmed (NASDAQ:PAVM) Issues FY 2020 Pre-Market Earnings Guidance
americanbankingnews.com - February 22 at 9:12 AM
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings - Yahoo FinanceThe Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings - Yahoo Finance
finance.yahoo.com - February 20 at 2:49 PM
PAVmed (NASDAQ:PAVM) Stock Price Down 6.7%PAVmed (NASDAQ:PAVM) Stock Price Down 6.7%
americanbankingnews.com - February 18 at 8:12 PM
PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST - Yahoo FinancePAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST - Yahoo Finance
finance.yahoo.com - February 18 at 7:48 PM
PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST - GlobeNewswirePAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST - GlobeNewswire
globenewswire.com - February 18 at 9:45 AM
PAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM ESTPAVmed Reschedules Business Update Conference Call on February 22, 2021 to 8:30 AM EST
finance.yahoo.com - February 18 at 9:45 AM
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmeds CarpX(R) DeviceFirst U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed's CarpX(R) Device
marketwatch.com - February 17 at 6:08 PM
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device - Yahoo FinanceFirst U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device - Yahoo Finance
finance.yahoo.com - February 16 at 7:49 PM
PAVmed (NASDAQ:PAVM) Stock Price Up 28.3%PAVmed (NASDAQ:PAVM) Stock Price Up 28.3%
americanbankingnews.com - February 16 at 7:00 PM
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmeds CarpX® Device - GlobeNewswireFirst U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed's CarpX® Device - GlobeNewswire
globenewswire.com - February 16 at 9:43 AM
First U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® DeviceFirst U.S. Patient Undergoes Successful Minimally Invasive Carpal Tunnel Release Using PAVmed’s CarpX® Device
finance.yahoo.com - February 16 at 9:42 AM
Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027 - PRNewswireGlobal Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027 - PRNewswire
prnewswire.com - February 12 at 9:51 AM
PAVmeds Esophageal Diagnostic Tools Should Create Strong Shareholder Value - Seeking AlphaPAVmed's Esophageal Diagnostic Tools Should Create Strong Shareholder Value - Seeking Alpha
seekingalpha.com - February 10 at 9:35 AM
PAVmed to Hold Business Update Conference Call on February 22, 2021 - Yahoo FinancePAVmed to Hold Business Update Conference Call on February 22, 2021 - Yahoo Finance
finance.yahoo.com - February 10 at 9:35 AM
This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.